ACLX - Arcellx GAAP EPS of -$0.81 misses by $0.12 revenue of $14.96M beats by $2.37M
2023-11-14 01:59:56 ET
More on Arcellx
- Arcellx: Clinical Hold Lifted, Charting A Brighter Path Forward (Rating Upgrade)
- Arcellx jumps after data for Gilead-partnered multiple myeloma drug
- Seeking Alpha’s Quant Rating on Arcellx
- Historical earnings data for Arcellx
- Financial information for Arcellx
For further details see:
Arcellx GAAP EPS of -$0.81 misses by $0.12, revenue of $14.96M beats by $2.37M